Journal of Urology

The Journal of Urology is a peer-reviewed scientific journal of urology published by Elsevier on behalf of the American Urological Association. It was established in 1917. The journal is abstracted and indexed in BIOSIS, Current Contents/Clinical Medicine, EMBASE/Excerpta Medica, MEDLINE, Reference Update, and Scopus.

Publisher
Elsevier
History
1917–present
Website
http://www.jurology.com/

Some content from Wikipedia, licensed under CC BY-SA

Health

Inflammatory diet linked to testosterone deficiency in men

Consuming a diet high in pro-inflammatory foods—including foods that contain refined carbohydrates and sugar as well as polyunsaturated fats—may be associated with increased odds of developing testosterone deficiency ...

Oncology & Cancer

Meds for enlarged prostate tied to heart failure risk

(HealthDay)—Medications used for enlarged prostate are associated with a small, but significant, increase in developing heart failure, according to a study published online Feb. 22 in The Journal of Urology.

Cardiology

Medications for enlarged prostate linked to heart failure risk

Widely used medications for benign prostatic hyperplasia (BPH)—also known as enlarged prostate—may be associated with a small, but significant increase in the probability of developing heart failure, suggests a study ...

Oncology & Cancer

Study: New prostate cancer test could avoid unnecessary biopsies

A urine test based on University of Michigan Rogel Cancer Center research could have avoided one third of unnecessary prostate cancer biopsies while failing to detect only a small number of cancers, according to a validation ...

Oncology & Cancer

MRI frequently underestimates tumor size in prostate cancer

A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.

Oncology & Cancer

Evaluating the 'financial toxicity' of prostate cancer treatment

For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). ...

page 1 from 26